Astrana Health Inc. Concludes Significant Share Repurchase of 300,000 Shares

Astrana Health, Inc. Executes Strategic Share Repurchase

Astrana Health, Inc. recently made headlines by announcing the successful repurchase of 300,000 shares of its common stock. This strategic move, conducted on January 17, 2025, had an aggregate purchase price of $10.551 million, with each share purchased at $35.17—matching the closing price on the Nasdaq Stock Market on that date.

Brandon K. Sim, the company's President and CEO, emphasized that this repurchase illustrates the confidence management and the Board of Directors have in Astrana's ongoing performance. He remarked, "The share repurchase is a testament to management and the Board of Directors' confidence in the performance of Astrana Health. We remain committed to our strategic capital deployment practices and continue to prioritize long-term growth, including through opportunistic share repurchases."

The shares were sourced from Allied Physicians of California, a professional medical corporation that has been a longstanding stockholder and a consolidated affiliate of Astrana. The share repurchase was duly approved by both the Board of Directors and the Audit Committee, reflecting the strategic alignment of Astrana’s operations and investment approaches.

About Astrana Health, Inc.

Astrana Health, Inc., headquartered in Alhambra, California, stands at the forefront of provider-centric, technology-powered healthcare. The company has made it its mission to enable healthcare providers to deliver accessible, high-quality, and high-value care to patients. Operating on a proprietary, integrated healthcare delivery platform, Astrana empowers its network of over 12,000 providers to effectively participate in value-based care arrangements.

Currently, Astrana serves more than 1.1 million Americans, facilitating high-quality, cost-effective care through its diverse subsidiaries and affiliates, which include management service organizations (MSOs), independent practice associations (IPAs), accountable care organizations (ACOs), and various care delivery entities spanning primary, multi-specialty, and ancillary care.

The strategic share repurchase not only strengthens their capital structure but also positions Astrana favorably in the increasingly competitive healthcare landscape. As the healthcare industry continues to evolve, such measures highlight Astrana's commitment to fostering sustainable growth while enhancing shareholder value.

For individuals seeking more information on Astrana Health and its commitment to innovation in healthcare, it is encouraged to visit their official website at www.astranahealth.com. The future looks promising for Astrana as it continues to navigate the complex world of healthcare, driven by technology and a focused mission on patient-centered care.